Studies of magnesium in congenital long QT syndrome.
We studied the role of magnesium (Mg) in congenital long QT syndrome (LQTS). Twenty-two congenital LQTS patients and 30 control subjects were included in this study. We measured serum Mg (SMg) level and Mg retention (MgR) level, and evaluated the role of Mg (a high MgR level reflects Mg deficiency in the body). The influence of intravenous Mg infusion on Mg level was evaluated. Relatively low SMg level and high MgR level (LQTS:control = 53:33%, p < 0.01) were recognized in congenital LQTS patients, but there was an overlap with controls. Mg supplementation did not shorten QT interval and there was no significant correlation between Mg levels and QTc interval. Patients with syncopal history showed a higher MgR level (syncope (+):syncope (-) = 70:46%, p < 0.01) and intravenous Mg infusion improved Mg deficiency. These results suggest that some (not all) congenital LQTS patients are in a Mg-deficient state, which may be associated with syncope, and Mg supplementation may prevent recurrent syncope in these patients. Because there are several subtypes of congenital LQTS, perhaps with genetic testing Mg deficiency may be identified as a significant cofactor in some forms, whereas in other forms it is not relevant.
Hoshino
K
K
Department of Pediatric Cardiology, Saitama Children's Medical Center, Iwatsuki City, Japan.
Ogawa
K
K
Hishitani
T
T
Kitazawa
R
R
D019587:Dietary Supplements; D006801:Humans; D008133:Long QT Syndrome / Q000097:blood / Q000151:congenital*; D008274:Magnesium / Q000097:blood / Q000627:therapeutic use*; D013575:Syncope
D008274:Magnesium